Literature DB >> 26895766

Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.

Xiongzhi Wangpu1, Jiaoyang Lu1, Ruxing Xi1, Fei Yue1, Sumit Sahni1, Kyung Chan Park1, Sharleen Menezes1, Michael L H Huang1, Minhua Zheng1, Zaklina Kovacevic2, Des R Richardson2.   

Abstract

Metastasis is a complex process that is regulated by multiple signaling pathways, with the focal adhesion kinase (FAK)/paxillin pathway playing a major role in the formation of focal adhesions and cell motility. N-myc downstream regulated gene-1 (NDRG1) is a potent metastasis suppressor in many solid tumor types, including prostate and colon cancer. Considering the antimetastatic effect of NDRG1 and the crucial involvement of the FAK/paxillin pathway in cellular migration and cell-matrix adhesion, we assessed the effects of NDRG1 on this important oncogenic pathway. In the present study, NDRG1 overexpression and silencing models of HT29 colon cancer and DU145 prostate cancer cells were used to examine the activation of FAK/paxillin signaling and the formation of focal adhesions. The expression of NDRG1 resulted in a marked and significant decrease in the activating phosphorylation of FAK and paxillin, whereas silencing of NDRG1 resulted in an opposite effect. The expression of NDRG1 also inhibited the formation of focal adhesions as well as cell migration and cell-collagen adhesion. Incubation of cells with novel thiosemicarbazones, namely di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone and di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone, that upregulate NDRG1 also resulted in decreased phosphorylation of FAK and paxillin. The ability of these thiosemicarbazones to inhibit cell migration and metastasis could be mediated, at least in part, through the FAK/paxillin pathway.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895766      PMCID: PMC4851300          DOI: 10.1124/mol.115.103044

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  78 in total

1.  Mechanotransduction across the cell surface and through the cytoskeleton.

Authors:  N Wang; J P Butler; D E Ingber
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

Review 2.  Novel chelators for cancer treatment: where are we now?

Authors:  Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Antioxid Redox Signal       Date:  2012-05-11       Impact factor: 8.401

Review 3.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

4.  The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.

Authors:  Zaklina Kovacevic; Sherin Chikhani; Goldie Y L Lui; Sutharshani Sivagurunathan; Des R Richardson
Journal:  Antioxid Redox Signal       Date:  2012-05-08       Impact factor: 8.401

Review 5.  Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.

Authors:  Jing Sun; Daohai Zhang; Dong-Hun Bae; Sumit Sahni; Patric Jansson; Ying Zheng; Qian Zhao; Fei Yue; Minhua Zheng; Zaklina Kovacevic; Des R Richardson
Journal:  Carcinogenesis       Date:  2013-05-13       Impact factor: 4.944

6.  Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.

Authors:  David B Lovejoy; Danae M Sharp; Nicole Seebacher; Peyman Obeidy; Thomas Prichard; Christian Stefani; Maram T Basha; Philip C Sharpe; Patric J Jansson; Danuta S Kalinowski; Paul V Bernhardt; Des R Richardson
Journal:  J Med Chem       Date:  2012-08-03       Impact factor: 7.446

Review 7.  Paxillin comes of age.

Authors:  Nicholas O Deakin; Christopher E Turner
Journal:  J Cell Sci       Date:  2008-08-01       Impact factor: 5.285

8.  The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.

Authors:  Zaklina Kovacevic; Sharleen V Menezes; Sumit Sahni; Danuta S Kalinowski; Dong-Hun Bae; Darius J R Lane; Des R Richardson
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

9.  The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.

Authors:  Wensheng Liu; Fei Yue; Minhua Zheng; Angelica Merlot; Dong-Hun Bae; Michael Huang; Darius Lane; Patric Jansson; Goldie Yuan Lam Lui; Vera Richardson; Sumit Sahni; Danuta Kalinowski; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-04-20

10.  The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.

Authors:  Jiabei Wang; Dalong Yin; Changming Xie; Tongsen Zheng; Yingjian Liang; Xuehui Hong; Zhaoyang Lu; Xuan Song; Ruipeng Song; Haiyan Yang; Boshi Sun; Nishant Bhatta; Xianzhi Meng; Shangha Pan; Hongchi Jiang; Lianxin Liu
Journal:  Oncotarget       Date:  2014-09-30
View more
  13 in total

Review 1.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 2.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

3.  The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.

Authors:  Yun Yang; Youxun Liu; Rui Guo; Yun Fu; Ziheng Zhang; Pengfei Zhang; Pingxin Zhou; Tingting Wang; Tengfei Huang; Xiaotong Li; Changzheng Li
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

4.  N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3.

Authors:  Yan Song; Guangping Wu; Mingyang Zhang; Qianqian Kong; Juan Du; Yabing Zheng; Longtao Yue; Lili Cao
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

5.  Agrin has a pathological role in the progression of oral cancer.

Authors:  César Rivera; Flávia Silva Zandonadi; Celeste Sánchez-Romero; Ciro Dantas Soares; Daniela Campos Granato; Wilfredo Alejandro González-Arriagada; Adriana Franco Paes Leme
Journal:  Br J Cancer       Date:  2018-06-06       Impact factor: 7.640

6.  MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.

Authors:  Jiao Liu; Yangguang Shao; Yuxin He; Ke Ning; Xi Cui; Furong Liu; Zhenning Wang; Feng Li
Journal:  Cancer Sci       Date:  2018-12-21       Impact factor: 6.716

Review 7.  The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.

Authors:  Kyung Chan Park; Mahendiran Dharmasivam; Des R Richardson
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

8.  Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile.

Authors:  Ning Wang; Haiying Zhang; Xiulin Cui; Chao Ma; Linghui Wang; Wenguang Liu
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

9.  The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.

Authors:  Zhu-Ling Guo; Des R Richardson; Danuta S Kalinowski; Zaklina Kovacevic; Kian Cheng Tan-Un; Godfrey Chi-Fung Chan
Journal:  J Hematol Oncol       Date:  2016-09-27       Impact factor: 17.388

10.  N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.

Authors:  Sen Zhang; Chaoran Yu; Xiao Yang; Hiju Hong; Jiaoyang Lu; Wenjun Hu; Xiaohui Hao; Shuchun Li; Batuer Aikemu; Guang Yang; Zirui He; Luyang Zhang; Pei Xue; Zhenghao Cai; Junjun Ma; Lu Zang; Bo Feng; Fei Yuan; Jing Sun; Minhua Zheng
Journal:  J Exp Clin Cancer Res       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.